UNIVERSAL HEALTH REALTY INCOME TRUST
UNIVERSAL HEALTH REALTY INCOME TRUST
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Real Estate Investments | |||||||||||||||||
Real Estate Investment Property At Cost | 683 | 672 | 666 | 661 | 660 | 657 | 656 | 654 | 652 | 651 | 649 | 651 | |||||
Real Estate Investment Property Accumulated Deprec… | -326 | -319 | -313 | -307 | -299 | -293 | -287 | -281 | -275 | -269 | -262 | -259 | |||||
Real Estate Investment Property Net | 357 | 352 | 353 | 355 | 360 | 364 | 369 | 373 | 377 | 382 | 387 | 392 | |||||
Land | 57 | 57 | 57 | 57 | 57 | 57 | 57 | 57 | 57 | 57 | 57 | 58 | |||||
Real Estate Investments | 414 | 409 | 410 | 412 | 417 | 421 | 426 | 430 | 434 | 439 | 444 | 450 | |||||
Notes Receivable Gross | 82 | 82 | 82 | 82 | 82 | 83 | 83 | 83 | 83 | 83 | 83 | 83 | |||||
Investments | 496 | 491 | 492 | 494 | 500 | 504 | 509 | 513 | 517 | 522 | 527 | 533 | |||||
Investment Owned At Fair Value | 20 | 20 | 20 | 21 | 21 | 14 | 14 | 14 | 14 | 15 | 9 | 9 | |||||
Other Assets | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 6 | 6 | 8 | 8 | 8 | |||||
Intangible Assets Net Excluding Goodwill | 5 | 5 | 6 | 6 | 6 | 7 | 7 | 8 | 8 | 9 | 9 | 10 | |||||
Operating Lease Right Of Use Asset | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | |||||
Deferred Costs And Other Assets | - | - | - | - | - | - | - | - | - | - | 18 | 22 | |||||
Assets | 567 | 564 | 565 | 568 | 573 | 573 | 581 | 584 | 587 | 596 | 596 | 608 | |||||
Liabilities | |||||||||||||||||
Line Of Credit | 366 | 360 | 356 | 357 | 355 | 350 | 349 | 348 | 343 | 334 | 327 | 322 | |||||
Secured Debt | 18 | 18 | 18 | 19 | 19 | 19 | 19 | 20 | 20 | 33 | 33 | 39 | |||||
Interest Payable Current And Noncurrent | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | |||||
Accrued Liabilities And Other Liabilities | 15 | 14 | 14 | 11 | 11 | 10 | 10 | 13 | 10 | 10 | 14 | 14 | |||||
Operating Lease Liability | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | |||||
Liabilities | 423 | 416 | 413 | 409 | 408 | 401 | 401 | 403 | 396 | 400 | 395 | 398 | |||||
Stockholders Equity | |||||||||||||||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital Common Stock | 273 | 272 | 272 | 272 | 272 | 271 | 271 | 271 | 271 | 270 | 270 | 270 | |||||
Retained Earnings Accumulated Deficit | 874 | 868 | 863 | 859 | 855 | 850 | 845 | 841 | 837 | 831 | 826 | 822 | |||||
Cumulative Dividends | -1,005 | -995 | -984 | -974 | -964 | -954 | -943 | -933 | -923 | -913 | -903 | -893 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | 3 | 2 | 2 | 2 | 3 | 4 | 6 | 3 | 6 | 8 | 7 | 10 | |||||
Stockholders Equity | 144 | 148 | 152 | 159 | 165 | 172 | 180 | 182 | 191 | 196 | 201 | 210 | |||||
Liabilities And Stockholders Equity | 567 | 564 | 565 | 568 | 573 | 573 | 581 | 584 | 587 | 596 | 596 | 608 | |||||
Finite Lived Intangible Assets Accumulated Amortiz… | 12 | 11 | 11 | 11 | 11 | 12 | 11 | 12 | 11 | 11 | 13 | 13 | |||||
Preferred Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |||||
Preferred Stock Shares Authorized | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | |||||
Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |||||
Common Stock Shares Authorized | 95 | 95 | 95 | 95 | 95 | 95 | 95 | 95 | 95 | 95 | 95 | 95 | |||||
Common Stock Shares Issued | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | |||||
Shares Outstanding | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 1.84% | 7.51% | 9.87% | - | - | - | - | - | - | - | - | - |
| 2025 | 1.72% | 4.24% | 7.45% | 4.86% | 2.82% | -4.23% | 4.58% | 3.04% | 2.15% | -8.23% | -0.67% | -6.97% |
| 2024 | 1.21% | 7.44% | 19.74% | 6.45% | 9.71% | -2.79% | -0.85% | -12.45% | -8.55% | 3.01% | -1.25% | 1.86% |
| 2023 | - | - | - | -1.83% | -13.63% | -18.73% | 5.00% | 9.95% | 7.15% | -13.42% | -18.70% | -9.29% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Leverage & Debt | |||||||||||||||||
| Interest Coverage TTM | 1.91 | 1.86 | 1.84 | 1.86 | 1.87 | 1.92 | 1.95 | 1.93 | 1.94 | 1.86 | 1.85 | 2.04 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | 1.39 | 1.29 | 1.27 | 1.29 | 1.29 | 1.35 | 1.39 | 1.31 | 1.30 | 1.17 | 1.11 | 1.26 | |||||
| Free Cash Flow Per Share TTM | 3.48 | 3.57 | 3.55 | 3.52 | 3.50 | 3.39 | 3.40 | 3.20 | 2.67 | 2.68 | 2.56 | 2.70 | |||||
| Dividend Per Share TTM | 2.99 | 2.98 | 2.97 | 2.95 | 2.94 | 2.94 | 2.93 | 2.92 | 2.91 | 2.89 | 2.88 | 2.87 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | - | -499.36% | -499.68% | -504.68% | -495.80% | -504.50% | -507.65% | -507.91% | -493.96% | -473.16% | -462.68% | -448.07% | |||||
| Operating Profit Margin TTM | 136.40% | 3,690.00% | 3,725.94% | 3,866.27% | 3,839.12% | 3,991.99% | 4,079.38% | 3,974.61% | 3,871.10% | 3,532.30% | 3,313.85% | 3,321.96% | |||||
| Net Profit Margin TTM | 74.98% | 1,899.04% | 1,887.35% | 1,952.77% | 1,931.79% | 2,053.90% | 2,132.37% | 2,022.94% | 1,982.53% | 1,737.01% | 1,627.91% | 1,814.57% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | 2,668.75% | 3.18% | 3.44% | 2.34% | 1.98% | -2.57% | -4.65% | -6.56% | -5.41% | -1.58% | -0.21% | 2.34% | |||||
| Net Income Growth (1Y) | 7.47% | -4.60% | -8.45% | -1.21% | -0.63% | 15.21% | 24.90% | 4.17% | -2.03% | -19.42% | -27.02% | -83.72% | |||||
| EPS Growth (1Y) | 7.28% | -4.75% | -8.57% | -1.36% | -0.75% | 15.06% | 24.75% | 4.05% | -2.13% | -19.51% | -27.10% | -83.73% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | 31.51 | 30.74 | 29.61 | 28.52 | 28.58 | 27.55 | 23.90 | 30.55 | 25.89 | 26.45 | 32.21 | 26.17 | |||||
| P/B TTM | 4.22 | 3.71 | 3.42 | 3.23 | 3.10 | 2.99 | 2.56 | 3.06 | 2.45 | 2.19 | 2.47 | 2.17 | |||||
| P/S TTM | 23.62 | 583.76 | 558.85 | 556.87 | 552.14 | 565.89 | 509.56 | 617.98 | 513.21 | 459.44 | 524.35 | 474.87 | |||||
| Market Cap | 606.98M | 548.73M | 521.41M | 511.76M | 512.39M | 515.53M | 459.62M | 554.95M | 467.02M | 429.58M | 496.03M | 456.35M | |||||
| Enterprise Value | 600.16M | 541.67M | 514.72M | 504.85M | 505.83M | 508.56M | 452.53M | 548.58M | 461.44M | 421.88M | 487.82M | 447.99M | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | 48.15M | 49.43M | 49.09M | 48.65M | 48.34M | 46.78M | 46.91M | 44.19M | 36.86M | 36.99M | 35.32M | 37.18M | |||||
| Net Debt | -6.82M | -7.06M | -6.69M | -6.92M | -6.55M | -6.97M | -7.10M | -6.37M | -5.58M | -7.70M | -8.21M | -8.36M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| PEG Ratio | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| EV Revenue TTM | |||||||||||||||||
| EV FCF TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
UNIVERSAL HEALTH REALTY INCOME TRUST (UHT) — SEC Financial Statements & Analysis
UNIVERSAL HEALTH REALTY INCOME TRUST (UHT) is a real estate investment trusts company, incorporated in MD. UNIVERSAL HEALTH REALTY INCOME TRUST trades on NYSE as: UHT. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), UNIVERSAL HEALTH REALTY INCOME TRUST reported a 2668.75% year-over-year revenue growth, a Gross Profit Margin of -499.36% (TTM), a Price-to-Sales (P/S) ratio of 23.62x (TTM), a Price-to-Book (P/B) ratio of 4.22x (TTM), at a market cap of $606.98M. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- 2668.75%
- Gross Profit Margin TTM
- -499.36%
- P/S TTM
- 23.62x
- P/B TTM
- 4.22x
- Market Cap
- $606.98M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is UNIVERSAL HEALTH REALTY INCOME TRUST in?
UNIVERSAL HEALTH REALTY INCOME TRUST (UHT) operates in the Real Estate Investment Trusts industry.
What is UHT's market cap?
UNIVERSAL HEALTH REALTY INCOME TRUST (UHT) has a market capitalization of $606.98M as of 2026-06-30.
What is UHT's P/E ratio?
UNIVERSAL HEALTH REALTY INCOME TRUST (UHT)'s trailing twelve month P/E ratio is 31.51x as of 2026-06-30.
What exchange does UHT trade on?
UNIVERSAL HEALTH REALTY INCOME TRUST (UHT) trades on the NYSE.
Where is UNIVERSAL HEALTH REALTY INCOME TRUST incorporated?
UNIVERSAL HEALTH REALTY INCOME TRUST is incorporated in MD.